Literature DB >> 22380017

Fullerenes for cancer diagnosis and therapy: preparation, biological and clinical perspectives.

Zhiyun Chen1, Ruoqing Mao, Ying Liu.   

Abstract

Cancer is a major public health problem in the world. There is a great need to apply novel technologies and drugs to revolutionize multiple aspects of cancer diagnosis and therapy. Advances in nanotechnology and nanomaterials have the potential to achieve the objective of early diagnosis and early therapy of cancer in the future. During the past few years, fullerene and its derivatives have been considered as some of the most promising nanomaterials because of their unique properties that enable a variety of medicinal applications. They can deliver drugs or small therapeutic molecules to the cancer cells. In this review, we will discuss how fullerene derivatives have been introduced into the field of cancer diagnosis and therapy. It will be highlighted that fullerene derivatives are used as anti-tumor drugs. Furthermore, preparation, characterization, pharmacokinetics and bio-distribution of fullerene and its derivatives reported in recent years will be summarized.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22380017     DOI: 10.2174/138920012802850128

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  9 in total

1.  Investigation of work of adhesion of biological cell (human hepatocellular carcinoma) by AFM nanoindentation.

Authors:  Xinyao Zhu; Nan Zhang; Zuobin Wang; X Liu
Journal:  J Microbio Robot       Date:  2016-05-07

Review 2.  Safe clinical use of carbon nanotubes as innovative biomaterials.

Authors:  Naoto Saito; Hisao Haniu; Yuki Usui; Kaoru Aoki; Kazuo Hara; Seiji Takanashi; Masayuki Shimizu; Nobuyo Narita; Masanori Okamoto; Shinsuke Kobayashi; Hiroki Nomura; Hiroyuki Kato; Naoyuki Nishimura; Seiichi Taruta; Morinobu Endo
Journal:  Chem Rev       Date:  2014-04-10       Impact factor: 60.622

3.  A zeta potential value determines the aggregate's size of penta-substituted [60]fullerene derivatives in aqueous suspension whereas positive charge is required for toxicity against bacterial cells.

Authors:  Dmitry G Deryabin; Ludmila V Efremova; Alexey S Vasilchenko; Evgeniya V Saidakova; Elena A Sizova; Pavel A Troshin; Alexander V Zhilenkov; Ekaterina A Khakina; Ekaterina E Khakina
Journal:  J Nanobiotechnology       Date:  2015-08-08       Impact factor: 10.435

4.  A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents. [Corrected].

Authors:  Hai Wang; Pranay Agarwal; Shuting Zhao; Jianhua Yu; Xiongbin Lu; Xiaoming He
Journal:  Nat Commun       Date:  2015-12-01       Impact factor: 14.919

5.  Complex of C60 Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy.

Authors:  Svitlana V Prylutska; Larysa M Skivka; Gennadiy V Didenko; Yuriy I Prylutskyy; Maxim P Evstigneev; Grygoriy P Potebnya; Rostyslav R Panchuk; Rostyslav S Stoika; Uwe Ritter; Peter Scharff
Journal:  Nanoscale Res Lett       Date:  2015-12-29       Impact factor: 4.703

Review 6.  Nanoparticles for Cancer Therapy: Current Progress and Challenges.

Authors:  Shreelaxmi Gavas; Sameer Quazi; Tomasz M Karpiński
Journal:  Nanoscale Res Lett       Date:  2021-12-05       Impact factor: 4.703

7.  Fullerene Derivatives for Drug Delivery against COVID-19: A Molecular Dynamics Investigation of Dendro[60]fullerene as Nanocarrier of Molnupiravir.

Authors:  Georgios I Giannopoulos
Journal:  Nanomaterials (Basel)       Date:  2022-08-07       Impact factor: 5.719

8.  Fullerene Derivatives (CN-[OH]β) and Single-Walled Carbon Nanotubes Modelled as Transporters for Doxorubicin Drug in Cancer Therapy.

Authors:  Hakim Al Garalleh
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

Review 9.  Applications of nanoparticle systems in drug delivery technology.

Authors:  Syed A A Rizvi; Ayman M Saleh
Journal:  Saudi Pharm J       Date:  2017-10-25       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.